Open Access

One year after: what are the implications of the new The ESC/EAS LDL-c Guidelines for PCSK9i?

Topic: Lipid-Lowering Agents
Organised by PACE-CME, supported by Amgen and Sanofi in the form of an educational grant

Congress Presentation

About the speaker

Professor Francois Mach

Geneva University Hospitals, Geneva (Switzerland)
21 presentations
1 follower

4 more presentations in this session


Speaker: Professor J. Kastelein (Amsterdam, NL)


Five years of PCSK9i: Lessons from practice, which patients do benefit most?

Speaker: Professor E. Stroes (Amsterdam, NL)


Time to reduce the implementation gaps-the role of PCSK9i in routine practice

Speaker: Professor K. Ray (London, GB)



Speaker: Professor J. Kastelein (Amsterdam, NL)


Access the full session

PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities

Speakers: Professor F. Mach, Professor J. Kastelein, Professor E. Stroes, Professor K. Ray, Professor J. Kastelein

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb